Patent ID: 7964734

Claim:
Raloxifene DL-lactate anhydrate being in crystalline form having the following X-ray crystalline positions: XRD: D 2Theta I(rel) I(abs) FWHM 13.595814 6.4959 28.40 12683 0.1400 10.855533 8.1382 16.15 7211 0.1200 9.849394 8.9711 32.17 14369 0.1000 9.534325 9.2682 66.95 29898 0.1300 8.150249 10.8465 45.20 20188 0.1300 7.240730 12.2138 63.53 28374 0.1400 6.769843 13.0670 18.42 8227 0.1500 6.272666 14.1077 75.67 33794 0.1900 5.818832 15.2143 13.28 5933 0.2000 5.657337 15.6513 18.07 8070 0.1300 5.505030 16.0872 10.51 4692 0.1000 5.261933 16.8357 17.48 7806 0.1400 5.089504 17.4104 16.14 7210 0.1000 5.001569 17.7189 41.94 18732 0.0900 4.958950 17.8725 29.16 13023 0.1148 4.797388 18.4795 19.39 8660 0.1100 4.669322 18.9910 49.20 21972 0.1400 4.574684 19.3876 63.21 28227 0.1000 4.533019 19.5676 44.94 20071 0.1148 4.440548 19.9792 32.70 14604 0.1200 4.301886 20.6301 100.00 44659 0.1500 4.155406 21.3657 78.00 34833 0.1600 4.059049 21.8797 27.53 12296 0.1800 3.960846 22.4285 25.59 11427 0.1000 3.907408 22.7393 83.48 37282 0.1200 3.865461 22.9894 16.46 7350 0.1148 3.828892 23.2120 17.46 7798 0.0900 3.773130 23.5599 50.71 22649 0.1200 3.716486 23.9243 23.06 10300 0.1300 3.652238 24.3515 15.79 7053 0.1800 3.584725 24.8174 12.91 5764 0.1500 3.486791 25.5261 30.45 13600 0.1200 3.439149 25.8858 22.21 9919 0.1300 3.396267 26.2184 17.86 7978 0.1100 3.370045 26.4261 12.48 5572 0.1148 3.329320 26.7553 9.21 4113 0.1100 3.292728 27.0582 11.81 5274 0.1000 3.278070 27.1815 11.25 5026 0.1148 3.218620 27.6935 21.24 9485 0.1900 3.167986 28.1452 13.80 6162 0.0900 3.143230 28.3715 30.33 13546 0.1000 3.095423 28.9191 14.02 6260 0.1200 3.024921 29.5058 11.56 5161 0.1400 3.007253 29.6831 13.40 5984 0.1300.